@FiercePharma: Mylan leverages marketing savvy, price hikes to make EpiPen a go-to med. More | Follow @FiercePharma
@EricPFierce: We all know about drug recalls but who tops the list for device recalls? FierceMedicalDevices feature | Follow @EricPFierce
> Pfizer ($PFE) nabbed U.K. approval to market its three-month contraception injection for women to use at home. Story
> AdvaMed CEO Steve Ubl will likely succeed John Castellani as head of pharma industry trade group PhRMA. Article
> GlaxoSmithKline ($GSK) got an EU recommendation for its asthma med Nucala (mepolizumab). Statement
> AstraZeneca ($AZN) is planning to roll out data on its cancer drugs including Lynparza at the upcoming European Cancer Congress (ECC) in Vienna, Austria. More
> Nestle is expanding its global footprint with a new skin healthcare products factory in Brazil. Story
> Keryx Biopharmaceuticals ($KERX) scored EU approval for its Fexeric to treat hyperphosphatemia in adults with chronic kidney disease. Statement
Medical Device News
@FierceMedDev: ICYMI: LabCorp, China's Fosun Pharma, lead Asia-heavy $15B investment in Ativa Medical. FierceDiagnostics Item | Follow @FierceMedDev
@VarunSaxena2: Four key medical device recalls of 2015. Feature | Follow @VarunSaxena2
@EmilyWFierce: Human Longevity joins with South African insurer for $250 exome sequencing service. FierceDiagnostics story | Follow @EmilyWFierce
> Stealth surgical robotics startup from Intuitive Surgical co-founder raises $150M. More
> EU regulators crack down on Brazilian devicemaker for implant safety scare. Story
> St. Jude launches new patient-monitoring interface for CardioMEMS heart failure monitor. Article
Biotech News
@FierceBiotech: GlaxoSmithKline's asthma injection heads for EU approval. Story | Follow @FierceBiotech
@JohnCFierce: ICYMI: BIO boots Martin Shkreli's Turing out after pricing controversy erupts. Article | Follow @JohnCFierce
@DamianFierce: Hard to believe but the pope just described biotech valuations as "stretched." | Follow @DamianFierce
> Next-gen oncolytics upstart Replimune grabs a $30M transatlantic venture round. Report
> Concert Pharma's CF drug tops Vertex's top-seller in early study. Story
> GlaxoSmithKline's asthma injection heads for EU approval. Article
Vaccines News
> IDRI, Wellcome Trust to take tuberculosis jab to PhIIa in South Africa. Story
> Inovio-led team picks up $24M from DARPA to develop Ebola vaccine, treatments. Report
> Serum Institute sets out for dengue fast track. Article
> Scripps Florida nets 4-year, $6M grant from Gates Foundation for HIV vaccine. Story
> Advaxis reports 'encouraging' PhII cervical cancer vaccine data. More
CRO News
> U.K. CRO Venn buys up another contractor. Item
> ShangPharma plots a $60M splash for biologics R&D in China. Story
> German CRO cozies up to Bayer at its Berlin R&D hub. More
> Covance plots a deeper dive into manufacturing. Story
> BioClinica reaches into regulatory affairs with its latest buy. Article
Pharma Manufacturing News
> World's largest reinsurer ready to insure against FDA actions. Report
> Sun Pharma recalls more than 216,000 bottles after label leaches chemical. News
> Aesica plant to get power from biomass plant. More
> Mayne kicks off work on new $65M North Carolina plant. Story
> Pfizer finds buyer for Indian plant set to close this month. Article
Pharma Asia News
> Serum Institute of India throttles back on equity sale. Item
> China-focused RuiYi starts PhI in China on autoimmune candidate RYI-008. News
> HK-listed Lee's Pharmaceutical branches out further with Armetheon deal. More
> Japan's MHLW lines up about 50 candidates for fast-track 'sakigake' process. Story
> Australian subsidies for newer drugs go begging as companies avoid paper chase. Article
And Finally… Weight loss surgery could be a cost-effective way of lowering blood sugar for many diabetics, according to a new study. Article